Monocytes are a type of white blood cell that helps fight infections in your body. A high monocyte level may indicate inflammation, infection, blood disorders, and other health issues. Along with ...

Diarrhea occurs when a person has loose or watery stools. Many different conditions have diarrhea as a symptom. Treatment may include taking medications, making dietary changes, and staying ...

goodii by limiting the inflammatory monocyte outcomes. However, the evidence is still incomplete, as not enough evidence is provided to support that IL27 only acts at the level of HSCs and not ...

These particles affected monocytes, fibrocytes, and lymphocytes, leading to changes in gene expression and protein levels that may contribute to disease progression. Researchers examined CLL cell ...

What are the symptoms of chronic myeloid leukemia (CML)? Many people don’t have any symptoms when they're diagnosed with CML. It's often found when a person has blood tests done for another reason and ...

Imatinibis a commonly used antiproliferative agent for treating chronic myelogenous leukemia and gastrointestinal stromal tumors, and it is also thought to be effective in other areas, such as ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Psoriatic arthritis (PsA) is an inflammatory ...

Kolibaba, KS, Druker BJ. Current Status of Treatment for Chronic Myelogenous Leukemia. MedGenMed 2(2), 2000 [formerly published in Medscape Hematology-Oncology eJournal 3(2), 2000]. Available at ...

Emerging evidence implicates inflammation as a key driver of AF pathogenesis. 1 Our study aimed to investigate associations between circulating monocyte subsets, monocyte-attracting chemokines and ...

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis ...

A new study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months ...